A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis

NCT03653026 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

522

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis (UC)

Interventions

DRUG: Placebo
DRUG: Upadacitinib

Sponsor

AbbVie